Cargando…
Influence of anticardiolipin and anti‐β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification
BACKGROUND: Anticardiolipin (aCL) and anti‐β2 glycoprotein I (aβ2GPI) immunoglobulin (Ig) G/IgM antibodies are 2 of the 3 laboratory criteria for classification of antiphospholipid syndrome (APS). The threshold for clinically relevant levels of antiphospholipid antibodies (aPL) for the diagnosis of...
Autores principales: | Vanoverschelde, Laura, Kelchtermans, Hilde, Musial, Jacek, de Laat, Bas, Devreese, Katrien M. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611479/ https://www.ncbi.nlm.nih.gov/pubmed/31294336 http://dx.doi.org/10.1002/rth2.12207 |
Ejemplares similares
-
Brief Report on the 11th Meeting of the European Forum on Antiphospholipid Antibodies
por: Chayouâ, Walid, et al.
Publicado: (2019) -
Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
por: Devreese, Katrien M.J., et al.
Publicado: (2021) -
Application of the thrombin generation assay in patients with antiphospholipid syndrome: A systematic review of the literature
por: Gehlen, Rachel, et al.
Publicado: (2023) -
Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients
por: Trahtemberg, Uriel, et al.
Publicado: (2021) -
Anticardiolipin and anti-beta2-glycoprotein I antibodies in Behcet's disease.
por: Kang, H. J., et al.
Publicado: (1998)